ETFs positioned on Abbott Laboratories

Name YTD change Weight AuM
0.00% - 1 M€
+3.76% - 165 M€
+10.68% - 67 M€
+17.36% - 35,761 M€
+12.21% - 122 M€
+4.88% - 49 M€
+10.67% - 143 M€
+1.23% - 293 M€
+4.26% - 37 M€
+9.23% - 28 M€
+12.53% - 1,674 M€
+10.02% - 27,154 M€
+10.99% - 66 M€
-11.71%18.52% 3,478 M€
-13.43%17.54% 234 M€
+7.75%7.18% 61 M€
0.00%4.99% 5 M€
0.00%4.99% 4 M€
+9.89%4.99% 86 M€
+21.78%4.93% 513 M€
+18.01%4.77% 3,009 M€
+5.34%4.75% 33 M€
+32.00%4.32% 11 M€
+14.88%4.31% 941 M€
+18.04%4.19% 12 M€
+14.73%4% 28 M€
+17.94%3.89% 563 M€
+14.89%3.88% 140 M€
0.00%3.88% 9 M€
+17.12%3.77% 43,868 M€
+7.06%3.77% 56 M€
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
  1. Stock Market
  2. Stocks
  3. ABT Stock
  4. ETFs Abbott Laboratories